Hainan Shuangcheng Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BIVALIRUDIN, with a corresponding US DMF Number 30071.
Remarkably, this DMF maintains an Active status since its submission on January 26, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 04, 2016, and payment made on January 14, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II